Is there a role for upfront surgery in patients with N2 disease and good prognostic features?
作者信息
Lee Candice, Guel David A, Weksler Benny
机构信息
Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, Allegheny General Hospital, Pittsburgh, PA, USA.
出版信息
J Thorac Dis. 2019 May;11(Suppl 9):S1199-S1201. doi: 10.21037/jtd.2019.03.68.
Abstract
摘要
相似文献
1
Is there a role for upfront surgery in patients with N2 disease and good prognostic features?对于具有N2疾病且预后特征良好的患者， upfront手术是否有作用？
J Thorac Dis. 2019 May;11(Suppl 9):S1199-S1201. doi: 10.21037/jtd.2019.03.68.
2
Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer.可切除的病理N2期非小细胞肺癌患者 upfront 手术的长期预后
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):59-69. doi: 10.1093/ejcts/ezaa042.
3
Upfront surgery in patients with clinical skip N2 lung cancer based on results of modern radiological examinations.基于现代放射学检查结果对临床跳跃性N2期肺癌患者进行 upfront 手术。 （注：这里“upfront”不太好直接准确翻译，结合语境可理解为“先行的、前期的”等意思，具体准确意思需结合更多医学背景知识确定）
J Thorac Dis. 2018 Dec;10(12):6828-6837. doi: 10.21037/jtd.2018.10.115.
4
Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database.胸外科医师协会数据库中手术治疗的临床ⅢA期-临床N2期肺癌
Ann Thorac Surg. 2017 Aug;104(2):395-403. doi: 10.1016/j.athoracsur.2017.02.031. Epub 2017 May 17.
5
Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.新辅助化疗与 upfront 手术治疗 IIIA 期非小细胞肺癌患者纵隔淋巴结状态和复发模式的比较：单中心经验。
Thorac Cancer. 2017 Sep;8(5):393-401. doi: 10.1111/1759-7714.12447. Epub 2017 Jul 3.
6
The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.仅在伴有结外侵犯或多发N2转移的pN2期非小细胞肺癌中，放疗联合辅助化疗具有协同作用。
Lung Cancer. 2021 May;155:94-102. doi: 10.1016/j.lungcan.2021.03.011. Epub 2021 Mar 16.
7
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.对于特定的 IIIA 期非小细胞肺癌患者， upfront 手术作为一线治疗方法。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1814-1822.e4. doi: 10.1016/j.jtcvs.2017.10.075. Epub 2017 Nov 3.
8
Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.临床III期食管鳞状细胞癌患者新辅助化疗与先行手术加或不加化疗的比较。
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12473.
9
Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?纵隔淋巴结阳性（N2）可切除非小细胞肺癌的最佳治疗方法：手术的作用是什么？
Expert Rev Anticancer Ther. 2016 Nov;16(11):1131-1144. doi: 10.1080/14737140.2016.1240039. Epub 2016 Oct 6.
10
N2-IIIA non-small cell lung cancer: a plea for surgery!N2-IIIA期非小细胞肺癌：呼吁手术治疗！
J Thorac Dis. 2016 Nov;8(Suppl 11):S849-S854. doi: 10.21037/jtd.2016.09.34.
本文引用的文献
1
Upfront surgery in patients with clinical skip N2 lung cancer based on results of modern radiological examinations.基于现代放射学检查结果对临床跳跃性N2期肺癌患者进行 upfront 手术。 （注：这里“upfront”不太好直接准确翻译，结合语境可理解为“先行的、前期的”等意思，具体准确意思需结合更多医学背景知识确定）
J Thorac Dis. 2018 Dec;10(12):6828-6837. doi: 10.21037/jtd.2018.10.115.
2
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
3
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.NCCN 指南解读：非小细胞肺癌，第 5 版，2018 年。
J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.
4
Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy.非小细胞肺癌的临床分期：当前证据及对辅助化疗的意义
Ther Adv Med Oncol. 2017 Sep;9(9):599-609. doi: 10.1177/1758834017722746. Epub 2017 Aug 2.
5
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.IASLC 肺癌分期项目：对即将发布的（第八版）肺癌 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.
6
Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.ⅢA-N2期非小细胞肺癌诱导治疗与手术对比联合化疗和放疗的随机对照试验：一项系统评价和荟萃分析
J Thorac Dis. 2015 Aug;7(8):1414-22. doi: 10.3978/j.issn.2072-1439.2015.08.14.
7
Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.非小细胞肺癌的纵隔分期：计算机断层扫描与F-18-氟脱氧葡萄糖正电子发射断层扫描及计算机断层扫描对比
Cancer Imaging. 2014 Jun 3;14(1):23. doi: 10.1186/1470-7330-14-23.
8
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.非小细胞肺癌分期方法：肺癌的诊断与管理，第 3 版：美国胸科学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e211S-e250S. doi: 10.1378/chest.12-2355.
9
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.III期非小细胞肺癌的放疗联合化疗（无论是否进行手术切除）：一项III期随机对照试验
Lancet. 2009 Aug 1;374(9687):379-86. doi: 10.1016/S0140-6736(09)60737-6. Epub 2009 Jul 24.
10
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.基线可切除 IIIA-N2 期非小细胞肺癌的外科多模态治疗。纵隔淋巴结受累程度及对生存的影响。
Eur J Cardiothorac Surg. 2009 Sep;36(3):433-9. doi: 10.1016/j.ejcts.2009.04.013. Epub 2009 Jun 6.
Zotero 插件